Cargando…
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
Cancer immunotherapy has tremendous promise, but it has yet to be clinically applied in a wider variety of tumor situations. Many therapeutic combinations are envisaged to improve their effectiveness. In this way, strategies capable of inducing immunogenic cell death (e.g., doxorubicin, radiotherapy...
Autores principales: | Dias, Alexandre M. M., Courteau, Alan, Bellaye, Pierre-Simon, Kohli, Evelyne, Oudot, Alexandra, Doulain, Pierre-Emmanuel, Petitot, Camille, Walker, Paul-Michael, Decréau, Richard, Collin, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694944/ https://www.ncbi.nlm.nih.gov/pubmed/36365207 http://dx.doi.org/10.3390/pharmaceutics14112388 |
Ejemplares similares
-
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
por: Desvaux, Emiko, et al.
Publicado: (2018) -
IL-1RAP, a Key Therapeutic Target in Cancer
por: Frenay, Jame, et al.
Publicado: (2022) -
GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
por: Bouchard, Alexanne, et al.
Publicado: (2021) -
The HSP GRP94 interacts with macrophage intracellular complement C3 and impacts M2 profile during ER stress
por: Chaumonnot, Killian, et al.
Publicado: (2021) -
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
por: Silva, André C, et al.
Publicado: (2011)